127 related articles for article (PubMed ID: 29578937)
1. Determination of Tacrolimus Concentration and Protein Expression of P-Glycoprotein in Single Human Renal Core Biopsies.
Krogstad V; Vethe NT; Robertsen I; Hasvold G; Ose AD; Hermann M; Andersen AM; Chan J; Skauby M; Svensson MHS; Åsberg A; Christensen H
Ther Drug Monit; 2018 Jun; 40(3):292-300. PubMed ID: 29578937
[TBL] [Abstract][Full Text] [Related]
2. Validation of an LC-MS/MS method to measure tacrolimus in rat kidney and liver tissue and its application to human kidney biopsies.
Noll BD; Coller JK; Somogyi AA; Morris RG; Russ GR; Hesselink DA; Van Gelder T; Sallustio BC
Ther Drug Monit; 2013 Oct; 35(5):617-23. PubMed ID: 23921430
[TBL] [Abstract][Full Text] [Related]
3. Development and validation of a combined enzymatic-digestion/mass spectrometry assay for Tacrolimus quantitation in cardiac biopsies.
Molinaro M; Pellegrini C; Cattadori B; De Gregori S
J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Sep; 1152():122215. PubMed ID: 32615534
[TBL] [Abstract][Full Text] [Related]
4. Tacrolimus Can Be Reliably Measured With Volumetric Absorptive Capillary Microsampling Throughout the Dose Interval in Renal Transplant Recipients.
Vethe NT; Gustavsen MT; Midtvedt K; Lauritsen ME; Andersen AM; Åsberg A; Bergan S
Ther Drug Monit; 2019 Oct; 41(5):607-614. PubMed ID: 31584926
[TBL] [Abstract][Full Text] [Related]
5. Intracellular tacrolimus concentration correlates with impaired renal function through regulation of the IS-AHR-ABC transporter in peripheral blood mononuclear cells.
Guo P; Zhang R; Zhou J; Li P; Liu Y; Shi S
Int Immunopharmacol; 2024 Jan; 126():111233. PubMed ID: 37979449
[TBL] [Abstract][Full Text] [Related]
6. Low plasma concentrations of albumin influence the affinity column-mediated immunoassay method for the measurement of tacrolimus in blood during the early period after liver transplantation.
Tempestilli M; Di Stasio E; Basile MR; Elisei F; Antonini M; Ettorre GM; Iappelli M; Pucillo LP
Ther Drug Monit; 2013 Feb; 35(1):96-100. PubMed ID: 23191996
[TBL] [Abstract][Full Text] [Related]
7. Monitoring of tacrolimus concentrations in peripheral blood mononuclear cells: application to cardiac transplant recipients.
Lemaitre F; Antignac M; Fernandez C
Clin Biochem; 2013 Oct; 46(15):1538-41. PubMed ID: 23454394
[TBL] [Abstract][Full Text] [Related]
8. Expression of TGF-beta and fibrogenic genes in transplant recipients with tacrolimus and cyclosporine nephrotoxicity.
Khanna A; Plummer M; Bromberek C; Bresnahan B; Hariharan S
Kidney Int; 2002 Dec; 62(6):2257-63. PubMed ID: 12427154
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the Relationship Between Concentrations of Tacrolimus Metabolites, 13-O-Demethyl Tacrolimus and 15-O-Demethyl Tacrolimus, and Clinical and Biochemical Parameters in Kidney Transplant Recipients.
Zegarska J; Hryniewiecka E; Zochowska D; Samborowska E; Jazwiec R; Maciej K; Nazarewski S; Dadlez M; Paczek L
Transplant Proc; 2018 Sep; 50(7):2235-2239. PubMed ID: 30177142
[TBL] [Abstract][Full Text] [Related]
10. A high performance liquid chromatography tandem mass spectrometry for the quantification of tacrolimus in human bile in liver transplant recipients.
Tron C; Rayar M; Petitcollin A; Beaurepaire JM; Cusumano C; Verdier MC; Houssel-Debry P; Camus C; Boudjema K; Bellissant E; Lemaitre F
J Chromatogr A; 2016 Dec; 1475():55-63. PubMed ID: 27837999
[TBL] [Abstract][Full Text] [Related]
11. Measurement of calcineurin activity in peripheral blood mononuclear cells by ultra-high performance liquid chromatography-tandem mass spectrometry. Renal transplant recipients application (pharmacodynamic monitoring).
Fontova P; Rigo-Bonnin R; Vidal-Alabró A; Cerezo G; Bestard O; Cruzado JM; Torras J; Grinyó JM; Lloberas N
Clin Chim Acta; 2019 Aug; 495():287-293. PubMed ID: 31039337
[TBL] [Abstract][Full Text] [Related]
12. Comparative clinical trial of the variability factors of the exposure indices used for the drug monitoring of two tacrolimus formulations in kidney transplant recipients.
Marquet P; Albano L; Woillard JB; Rostaing L; Kamar N; Sakarovitch C; Gatault P; Buchler M; Charpentier B; Thervet E; Cassuto E
Pharmacol Res; 2018 Mar; 129():84-94. PubMed ID: 29229354
[TBL] [Abstract][Full Text] [Related]
13. Determination of tacrolimus in human whole blood in kidney transplant recipients using a rapid and specific LC-MS/MS method.
Hieu TB; Dung NM; Toan PQ; Kien TQ; Van Duc N; Thang LV; Van Tran P; Hop VQ; Phuong NM; Ben NH; Van Khoi N; Nghia TT; Dung VD; Van Thinh N; Hang DTT; Van Men C; Long DD; Su HX
J Clin Lab Anal; 2023 Aug; 37(15-16):e24958. PubMed ID: 37621139
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of a sensitive and selective LC-MS/MS method for determination of tacrolimus in oral fluids.
Ghareeb M; Akhlaghi F
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Dec; 1038():136-141. PubMed ID: 27771258
[TBL] [Abstract][Full Text] [Related]
15. Time of drug administration, CYP3A5 and ABCB1 genotypes, and analytical method influence tacrolimus pharmacokinetics: a population pharmacokinetic study.
Musuamba FT; Mourad M; Haufroid V; Delattre IK; Verbeeck RK; Wallemacq P
Ther Drug Monit; 2009 Dec; 31(6):734-42. PubMed ID: 19855314
[TBL] [Abstract][Full Text] [Related]
16. CYP3A5 and CYP3A4 but not MDR1 single-nucleotide polymorphisms determine long-term tacrolimus disposition and drug-related nephrotoxicity in renal recipients.
Kuypers DR; de Jonge H; Naesens M; Lerut E; Verbeke K; Vanrenterghem Y
Clin Pharmacol Ther; 2007 Dec; 82(6):711-25. PubMed ID: 17495880
[TBL] [Abstract][Full Text] [Related]
17. Tacrolimus concentrations in relation to CYP3A and ABCB1 polymorphisms among solid organ transplant recipients in Korea.
Jun KR; Lee W; Jang MS; Chun S; Song GW; Park KT; Lee SG; Han DJ; Kang C; Cho DY; Kim JQ; Min WK
Transplantation; 2009 Apr; 87(8):1225-31. PubMed ID: 19384171
[TBL] [Abstract][Full Text] [Related]
18. Quantification of tacrolimus and three demethylated metabolites in human whole blood using LC-ESI-MS/MS.
Dubbelboer IR; Pohanka A; Said R; Rosenborg S; Beck O
Ther Drug Monit; 2012 Apr; 34(2):134-42. PubMed ID: 22406653
[TBL] [Abstract][Full Text] [Related]
19. Influence of CYP3A4, CYP3A5 and MDR-1 polymorphisms on tacrolimus pharmacokinetics and early renal dysfunction in liver transplant recipients.
Shi Y; Li Y; Tang J; Zhang J; Zou Y; Cai B; Wang L
Gene; 2013 Jan; 512(2):226-31. PubMed ID: 23107770
[TBL] [Abstract][Full Text] [Related]
20. Monitoring the Intracellular Tacrolimus Concentration in Kidney Transplant Recipients with Stable Graft Function.
Han SS; Yang SH; Kim MC; Cho JY; Min SI; Lee JP; Kim DK; Ha J; Kim YS
PLoS One; 2016; 11(4):e0153491. PubMed ID: 27082871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
